|
US20160000902A1
(en)
*
|
2003-07-11 |
2016-01-07 |
Novavax, Inc. |
Combination vaccine for respiratory syncytial virus and influenza
|
|
WO2007070660A2
(en)
|
2005-12-13 |
2007-06-21 |
President And Fellows Of Harvard College |
Scaffolds for cell transplantation
|
|
US9770535B2
(en)
|
2007-06-21 |
2017-09-26 |
President And Fellows Of Harvard College |
Scaffolds for cell collection or elimination
|
|
JP5711972B2
(ja)
*
|
2007-12-24 |
2015-05-07 |
アイディー バイオメディカル コーポレイション オブ ケベック |
組換えｒｓｖ抗原
|
|
US9370558B2
(en)
|
2008-02-13 |
2016-06-21 |
President And Fellows Of Harvard College |
Controlled delivery of TLR agonists in structural polymeric devices
|
|
CN102006891B
(zh)
|
2008-02-13 |
2017-04-26 |
哈佛学院董事会 |
连续的细胞程序化装置
|
|
US11446374B2
(en)
|
2008-12-09 |
2022-09-20 |
Novavax, Inc. |
Modified RSV F proteins and methods of their use
|
|
PL2370099T3
(pl)
|
2008-12-09 |
2016-10-31 |
|
Zmodyfikowane białka F RSV i sposoby ich zastosowania
|
|
EP2445527A2
(en)
*
|
2009-06-24 |
2012-05-02 |
ID Biomedical Corporation of Quebec |
Vaccine
|
|
HUE028085T2
(en)
*
|
2009-06-24 |
2016-11-28 |
Glaxosmithkline Biologicals Sa |
Recombinant RSV antigens
|
|
CA2768186A1
(en)
|
2009-07-15 |
2011-01-20 |
Novartis Ag |
Rsv f protein compositions and methods for making same
|
|
CN103977394B
(zh)
*
|
2009-07-17 |
2016-03-09 |
翰林大学校产学协力团 |
包含脂质体包胶的寡核苷酸和表位的免疫刺激性组合物
|
|
AU2010278702C1
(en)
|
2009-07-31 |
2016-07-14 |
Forsyth Dental Infirmary For Children |
Programming of cells for tolerogenic therapies
|
|
US8846056B2
(en)
*
|
2009-08-04 |
2014-09-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control |
Anti-RSV immunogens and methods of immunization
|
|
CN106008716B
(zh)
|
2010-07-07 |
2019-08-13 |
人工细胞科技公司 |
呼吸道合胞病毒抗原组合物和方法
|
|
CN107648668B
(zh)
|
2010-10-06 |
2021-06-18 |
哈佛学院董事会 |
用于基于材料的细胞疗法的可注射的成孔水凝胶
|
|
CN103339140A
(zh)
*
|
2011-01-28 |
2013-10-02 |
米迪缪尼有限公司 |
哺乳动物细胞中可溶性病毒融合糖蛋白的表达
|
|
JP2014518620A
(ja)
*
|
2011-04-26 |
2014-08-07 |
モレキュラー エクスプレス，インコーポレイテッド |
リポソーム製剤
|
|
US10045947B2
(en)
|
2011-04-28 |
2018-08-14 |
President And Fellows Of Harvard College |
Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
|
|
US9675561B2
(en)
|
2011-04-28 |
2017-06-13 |
President And Fellows Of Harvard College |
Injectable cryogel vaccine devices and methods of use thereof
|
|
CA2835644C
(en)
|
2011-05-13 |
2021-06-15 |
Novartis Ag |
Pre-fusion rsv f antigens
|
|
EP2714073B1
(en)
|
2011-06-03 |
2021-03-10 |
President and Fellows of Harvard College |
In situ antigen-generating cancer vaccine
|
|
ES2395677B1
(es)
*
|
2011-07-29 |
2013-12-26 |
Instituto De Salud Carlos Iii |
Proteína F del VRSH en conformación pre-fusión estabilizada y anticuerpos neutralizantes específicos frente a la misma.
|
|
JP6085886B2
(ja)
|
2011-08-29 |
2017-03-01 |
国立大学法人徳島大学 |
Ｒｓｖ粘膜ワクチン
|
|
RU2014117068A
(ru)
*
|
2011-09-30 |
2015-11-10 |
Новавакс, Инк. |
Вакцина на основе рекомбинантных наночастиц f из rsv против респираторно-синцитиального вируса
|
|
HK1210479A1
(en)
|
2012-04-10 |
2016-04-22 |
The Trustees Of The University Of Pennsylvania |
Human respiratory syncytial virus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
|
|
DK2838515T3
(da)
|
2012-04-16 |
2020-02-24 |
Harvard College |
Mesoporøse siliciumdioxidsammensætninger til modulering af immunresponser
|
|
KR102435054B1
(ko)
*
|
2012-08-01 |
2022-08-22 |
버베리안 노딕 에이/에스 |
재조합 변형된 백시니아 바이러스 앙카라(ankara) (mva) 호흡기 신시티알 바이러스(rsv) 백신
|
|
DK2879702T3
(da)
*
|
2012-08-01 |
2020-02-24 |
Bavarian Nordic As |
Rekombinant modificeret vacciniavirus ankara (mva)-vaccine mod respiratorisk syncytialvirus (rsv)
|
|
AU2013301312A1
(en)
|
2012-08-06 |
2015-03-19 |
Glaxosmithkline Biologicals S.A. |
Method for eliciting in infants an immune response against RSV and B. pertussis
|
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
|
KR20150138184A
(ko)
*
|
2013-02-11 |
2015-12-09 |
노바백스, 인코포레이티드 |
호흡기 세포 융합 바이러스 및 인플루엔자를 위한 조합 백신
|
|
MX2016001695A
(es)
|
2013-08-05 |
2016-05-02 |
Glaxosmithkline Biolog Sa |
Composiciones inmunogenas de combinacion.
|
|
EP3137105A4
(en)
|
2014-04-30 |
2017-12-27 |
President and Fellows of Harvard College |
Combination vaccine devices and methods of killing cancer cells
|
|
MX384992B
(es)
|
2014-06-13 |
2025-03-14 |
Glaxosmithkline Biologicals Sa |
Combinaciones inmunógenas.
|
|
US11786457B2
(en)
|
2015-01-30 |
2023-10-17 |
President And Fellows Of Harvard College |
Peritumoral and intratumoral materials for cancer therapy
|
|
WO2016164705A1
(en)
|
2015-04-10 |
2016-10-13 |
Omar Abdel-Rahman Ali |
Immune cell trapping devices and methods for making and using the same
|
|
CA2996007A1
(en)
|
2015-09-03 |
2017-03-09 |
Novavax, Inc. |
Vaccine compositions having improved stability and immunogenicity
|
|
RU2723039C2
(ru)
|
2015-12-23 |
2020-06-08 |
Пфайзер Инк. |
Мутанты белка f rsv
|
|
US11752238B2
(en)
|
2016-02-06 |
2023-09-12 |
President And Fellows Of Harvard College |
Recapitulating the hematopoietic niche to reconstitute immunity
|
|
CN109789092A
(zh)
|
2016-07-13 |
2019-05-21 |
哈佛学院院长等 |
抗原呈递细胞模拟支架及其制备和使用方法
|
|
IL264557B2
(en)
|
2016-08-02 |
2024-01-01 |
Harvard College |
Biological agents for regulating immune responses
|
|
JP7044222B2
(ja)
|
2016-08-03 |
2022-03-30 |
ロンザ ウォーカーズヴィル，インコーポレーテッド |
実質的にコアギュローゲンを含まないリムルスアメボサイトライセートを使用してエンドトキシンを検出する方法
|
|
GB201620968D0
(en)
|
2016-12-09 |
2017-01-25 |
Glaxosmithkline Biologicals Sa |
Adenovirus polynucleotides and polypeptides
|
|
WO2018132562A1
(en)
|
2017-01-11 |
2018-07-19 |
Lonza Walkersville, Inc. |
Coagulogen-free clarified limulus amebocyte lysate
|
|
JP7317796B2
(ja)
|
2017-07-24 |
2023-07-31 |
ノババックス，インコーポレイテッド |
呼吸器疾患を治療するための方法および組成物
|
|
JP2021500880A
(ja)
|
2017-10-16 |
2021-01-14 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
２つの発現カセットを有するサルアデノウイルスベクター
|
|
EP3697902A1
(en)
|
2017-10-16 |
2020-08-26 |
GlaxoSmithKline Biologicals S.A. |
Enhanced promoter
|
|
EP3697919A1
(en)
|
2017-10-16 |
2020-08-26 |
GlaxoSmithKline Biologicals SA |
Adenoviral vectors with two expression cassettes encoding rsv antigenic proteins or fragments thereof
|
|
US11905313B2
(en)
|
2017-11-28 |
2024-02-20 |
The United States of America, as represented by the Secretary, Department of Health and Human Services. |
Recombinant RSV G proteins and their use
|
|
CN120227451A
(zh)
|
2018-03-19 |
2025-07-01 |
诺瓦瓦克斯股份有限公司 |
多价流感纳米颗粒疫苗
|
|
EP3807298A1
(en)
|
2018-06-12 |
2021-04-21 |
GlaxoSmithKline Biologicals S.A. |
Adenovirus polynucleotides and polypeptides
|
|
WO2020061129A1
(en)
|
2018-09-19 |
2020-03-26 |
President And Fellows Of Harvard College |
Compositions and methods for labeling and modulation of cells in vitro and in vivo
|
|
KR102725189B1
(ko)
|
2018-11-01 |
2024-10-31 |
에스케이바이오사이언스(주) |
재조합 호흡기 세포융합 바이러스 f 단백질 및 이를 포함하는 백신 조성물
|
|
EP3932424A4
(en)
|
2019-02-28 |
2022-10-12 |
KM Biologics Co., Ltd. |
Rsv f/g chimeric vaccine
|
|
WO2021061837A1
(en)
|
2019-09-23 |
2021-04-01 |
President And Fellows Of Harvard College |
Biomaterial-based antigen free vaccine and the use thereof
|
|
CN114993784B
(zh)
*
|
2022-05-27 |
2025-07-29 |
重庆医科大学 |
一种乙肝病毒颗粒裂解液及其制备与应用
|
|
WO2025263563A1
(ja)
*
|
2024-06-20 |
2025-12-26 |
Ｋｍバイオロジクス株式会社 |
ＲＳＶ ＦＧキメラｍＲＮＡワクチン
|